Third Party Funding
2002-2006: DFG, Junior group grant within the collaborative research center 405 - The regulation of Natural Killer cells - lessons learned from the 2B4 (CD244) receptor
2005-2007: Deutsche Krebsstiftung - Identification of the ligands for the 'natural cytotoxicity receptors'NKp30, NKp44 and NKp46
2005-2011: German Ministry for Science and Education (BMBF) BioFuture - The role of lipid rafts in the activation and function of human Natural Killer cells
2006-2009: DFG, Subproject A13 within the collaborative research center 405 - Modulation of lymphocyte activities by SLAM-related receptors
2007-2008: German Cancer Foundation - Role of SLAM family receptors in the activation of gamma/delta T cells
2007-2011: German Ministry for Science and Education (BMBF)-Systems Biology of Cancer (SBCancer) - Cellular Decisions in Natural Killer cells
2009: DFG, Individual grant - Identification and functional characterization of proteins associated with membrane fractions surrounding activating and inhibitory Natural Killer cell receptors
2008-2010: German Cancer Foundation - Identification of the ligands for the 'natural cytotoxicity receptors' NKp30, NKp44 und NKp46
2008-2011: Graduate Academy of the state Baden Württemberg - Differential activation and integration of signaling modules within the immune system1 PhD student stipend
2010-2013: DFG, Subproject 16 within the transregional collaborative research center (TRR) 83 - Identification and functional characterization of proteins associated with membrane fractions surrounding activating and inhibitory Natural Killer cell receptors
2010-2013: University Regensburg, DFG funded grant CA933/1-1) within the research unit FOR696 - Molecular Analyses and Interactions at Articular InterfacesRole of tyrosine hydroxylase (TH) – positive cells in arthritisapprox
2011-2013: DFG, Individual grant - 'SLAM-related receptors': role of the cis/trans interaction in the regulation of Natural Killer cells and function on T cells
2013-2016: Leibniz SAW Procedure - Defining Natural Killer Cell reactivity by quantitative analysis of activating and inhibitory receptor signal integration
2015-2016: Start-up price funded by the DGRh - The dopamine pathway: a potential therapeutic target for local treatment of rheumatoid arthritis
2016-2018: MARIE CURIE individual Fellowship (EU Horizon2020) - Dopamine and bone metabolism in rheumatoid arthritis
2018-2020: DFG, Individual grant - The role of conventional and liver resident NK cells in drug-induced liver injury and in the regulation of ILC2 cells
2020: Leibniz-Institut für Pflanzenbiochemie (IPB), Individual grant - Development of SPR-based immunoassays for measuring anti-CoV-2 antibodies and for detecting Interactions between CoV-2 spike and virus entry receptor ACE2 at very low concentrations (Seed Money)
2020-2023: DFG, Individual grantRegulation of Natural Killer Cell Functions by Catecholamines
2020-2022: Bundesministerium für Bildung und Forschung Joint-Project: The Role of Epitranscriptomic Modifications in Regulating the Activity of Natural Killer Cells against Tumors - Sub-Project: The effect of manipulating m6A modifications on the activity of NK cells
2021-2022: Volkswagen Foundation - Novel testing strategies for SARS-CoV-2 virus surveillance and determination of immunity
January 2023 - April 2025: Ergonsim – Human Thermal Modelling/Bundesrepublik Deutschland, Bundesministerium der Verteidigung, Zentrum für Geoinformationswesen der Bundeswehr (ZGeoInf) - Development of the Universal Thermal Climate Index for military applications (UTCI.mil)
December 2024 - March 2025: Rheumazentrum Herne/Lilly Deutschland GmbH - Impact of sex on treatment response in patients with axial Spondyloarthritis - a biomarker approach
2025-2027: DFG - Improvement of NK cell activity to combat aggressive B-cell lymphomas